UCL Institute of Cardiovascular Science retweetou

The weight loss drug semaglutide may help to prevent heart attacks and other major cardiac events among overweight people with cardiovascular disease, whether or not they also have heart failure, finds a new study led by Prof John Deanfield @UCL_ICS ucl.ac.uk/news/2024/aug/…
English








